Literature DB >> 22349873

Isolated motor conduction block associated with infliximab.

A W Michell, A Gaitatzis, J Burge, M M Reilly, R Kapoor, M Koltzenburg.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22349873     DOI： 10.1007/s00415-012-6452-3

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  13 in total

1.  Multifocal motor neuropathy with conduction block following treatment with infliximab.

Authors:  Claire E Barber; Peter Lee; A Hillary Steinhart; Jason Lazarou
Journal:  J Rheumatol       Date:  2010-08-01       Impact factor: 4.666

2.  Motor neuropathy with multiple conduction blocks associated with TNF-alpha antagonist.

Authors:  Paulo Eduardo Mestrinelli Carrilho; Allan César Faria Araújo; Orival Alves; Paulo Gustavo Kotze
Journal:  Arq Neuropsiquiatr       Date:  2010-06       Impact factor: 1.420

3.  Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy.

Authors:  C Rodriguez-Escalera; J Belzunegui; L Lopez-Dominguez; C Gonzalez; M Figueroa
Journal:  Rheumatology (Oxford)       Date:  2005-01       Impact factor: 7.580

4.  Acute neuropathy with multiple conduction blocks after TNFalpha monoclonal antibody therapy.

Authors:  Oliver C Singer; Bettina Otto; Helmuth Steinmetz; Ulf Ziemann
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

5.  Multifocal motor neuropathy during treatment with infliximab.

Authors:  Dario Cocito; Bruno Bergamasco; Alessia Tavella; Fabio Poglio; Ilaria Paolasso; Paolo Costa; Palma Ciaramitaro; Gianluca Isoardo
Journal:  J Peripher Nerv Syst       Date:  2005-12       Impact factor: 3.494

6.  Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.

Authors:  Maria G Tektonidou; John Serelis; Fotini N Skopouli
Journal:  Clin Rheumatol       Date:  2006-07-06       Impact factor: 2.980

7.  A case of spontaneously recovering multifocal motor neuropathy with conduction blocks (MMNCB) during anti-TNF alpha therapy for ankylosing spondylitis.

Authors:  Giuseppe Paolazzi; Susanna Peccatori; Francesco P Cavatorta; Alberto Morini
Journal:  Clin Rheumatol       Date:  2009-04-07       Impact factor: 2.980

8.  Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.

Authors:  Laurence Fardet; Alain Dupuy; Delphine Kerob; Annabelle Levy; Matthieu Allez; Edouard Begon; Hervé Bachelez; Patrice Morel; Celeste Lebbé
Journal:  J Am Acad Dermatol       Date:  2007-01-22       Impact factor: 11.527

9.  Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis.

Authors:  Pascal Richette; Philippe Dieudé; Joël Damiano; Frédéric Lioté; Philippe Orcel; Thomas Bardin
Journal:  J Rheumatol       Date:  2004-10       Impact factor: 4.666

10.  Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series.

Authors:  Stephen J Jarrett; Gaye Cunnane; Philip G Conaghan; Sarah J Bingham; Maya H Buch; Mark A Quinn; Paul Emery
Journal:  J Rheumatol       Date:  2003-10       Impact factor: 4.666
View more
  1 in total

1.  Non-length-dependent and length-dependent small-fiber neuropathies associated with tumor necrosis factor (TNF)-inhibitor therapy in patients with rheumatoid arthritis: expanding the spectrum of neurological disease associated with TNF-inhibitors.

Authors:  Julius Birnbaum; Clifton O Bingham
Journal:  Semin Arthritis Rheum       Date:  2013-10-30       Impact factor: 5.532
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.